GM1146, SB2181 SD2 HD2, 4/29/2016

Posted on Apr 29, 2016 in 2016 Vetos

RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Permits manufacturers of investigational drugs or biological products beginning on January 1, 2017 to make these drugs and products available to terminally ill patients under certain conditions.

Veto GM1146, SB2181 SD2 HD2